[go: up one dir, main page]

WO2006038798A1 - Procede pour former une membrane lipidique comprenant des couches lipidiques empilees, support pourvu d'une telle membrane et utilisation de celle-ci - Google Patents

Procede pour former une membrane lipidique comprenant des couches lipidiques empilees, support pourvu d'une telle membrane et utilisation de celle-ci Download PDF

Info

Publication number
WO2006038798A1
WO2006038798A1 PCT/NL2005/000716 NL2005000716W WO2006038798A1 WO 2006038798 A1 WO2006038798 A1 WO 2006038798A1 NL 2005000716 W NL2005000716 W NL 2005000716W WO 2006038798 A1 WO2006038798 A1 WO 2006038798A1
Authority
WO
WIPO (PCT)
Prior art keywords
lipid
support
membrane
lipid mixture
layers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/NL2005/000716
Other languages
English (en)
Other versions
WO2006038798A8 (fr
Inventor
Miranda Wilhelmina De Jager
Johanna Aaltje Bouwstra
Maria Helen Ponec-Waelsch
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Stichting voor de Technische Wetenschappen STW
Original Assignee
Stichting voor de Technische Wetenschappen STW
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stichting voor de Technische Wetenschappen STW filed Critical Stichting voor de Technische Wetenschappen STW
Publication of WO2006038798A1 publication Critical patent/WO2006038798A1/fr
Publication of WO2006038798A8 publication Critical patent/WO2006038798A8/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G01N33/5432—Liposomes or microcapsules

Definitions

  • the present invention relates to a method- of forming a lipid membrane comprising stacked lipid layers using a lipid mixture con ⁇ taining at least 1 ceramide and capable of forming a stack of lipid layers, said method comprising the steps of a) dissolving lipids in a solvent to yield a solution containing a lipid mixture, b) applying the solution containing the lipid mixture to a support, c) allowing the solvent to evaporate in order to yield a support pro ⁇ vided with a lipid membrane, d) subjecting the support provided with a lipid membrane to a heat treatment to yield a support having a lipid membrane enriched in structured lipid layers.
  • the stratum corneum This outermost layer of skin is characterized by cells (corneocytes) that are embed- ded in a matrix of stacked lipid layers.
  • These lipid layers have a unique composition as well as a unique structure. They contain, apart from lipids that are present in the body more generally, such as cho ⁇ lesterol, special free fatty acids having long chains and ceramides. Each ceramide molecule comprises two long hydrocarbon chains, usually of different length.
  • the first chain is referred to as an acyl chain.
  • the second chain is referred to as a non-fatty acid chain, and is part of the sphingoid basic structure.
  • Kuem- pel et al disclose a method of forming a lipid membrane on a support, said lipid membrane consisting of stacked lipid layers (lamellae) .
  • Kuempel et al disclose a method for the preparation of lipid layers having the best possible imitation of (healthy) skin de ⁇ sired for long periodicity of about 13 run.
  • the known method comprises the application of a solution containing a lipid mixture on a disc-shaped support by repeatedly pipetting. Between the individual applications the solvent is left to evaporate, yielding a lipid mem- brane.
  • a heat treatment is performed. During this heat treatment the supports, with on top of them the lipid membrane, are hydrated by hanging them in distilled water and heating them at 80 0 C. After cooling, the disc-shaped support is dried, whereby which the long periodicity in the lipid membrane is formed.
  • a disadvantage of the known method is that the lipid layers thus formed may contain inhomogeneities, which may be visible as holes with electron microscopy, as a result of which they are useless for the intended purpose of permeability research.
  • the objective of the present invention is to provide a method according to the preamble, wherein said disadvantage is largely or even completely eliminated.
  • the present invention is characterized in that i) the solution containing lipids of step b) is applied by means of a spraying method, such that the droplets formed using the spraying method do reach the substrate as droplets ii) the heat treatment of step d) comprises heating to a temperature below the melting point or melting range of the lipid mixture on the substrate, whereupon the lipid mixture thus heated is cooled in the absence of contact with an aqueous solution by at least 10 0 C, yield ⁇ ing the lipid membrane comprising stacked lipid layers.
  • the method according to the present invention yields a homogeneous lipid membrane comprising stacked lipids layers having no or virtually no holes and which, con ⁇ sequently, is useful for diffusion or penetration-experiments.
  • the present invention is not limited to a specific lipids com ⁇ position.
  • the lipid mixture com ⁇ prises at least 1 acyl ceramide capable of forming lipid layers hav ⁇ ing long periodicity or capable of enhancing the formation of such lipid layers having long periodicity.
  • acyl ceramides In the skin unique ceramide molecules are present, called acyl ceramides, said ceramides containing, apart from the above mentioned (first) acyl chain, a second acyl chain.
  • This second acyl chain is present at the end of the first acyl chain that is not attached di- rectly to the sphingoid basic structure; in other words, the second acyl chain is linked indirectly to the sphingoid basic structure.
  • acyl ceramide molecules which have an elongated acyl chain are essential for forming the unique structure of the lipid layers in the stratum corneum, as can be made visible with electron microscopy and can be detected with X-ray diffraction.
  • lipid membrane com- prising stacked lipid layers having a long periodicity in any case >8 nm, usually ca 13 nm instead of ca 5 nm
  • these lipid membranes being extremely suitable for diffusion or penetration experiments be ⁇ cause of their structure and their virtual absence of inhomogeneity.
  • the lipid composition will have to be chosen such that it is suitable for providing stacked lipid layers having a long periodicity.
  • the ordinary person skilled in the art may, if necessary, start with the composition disclosed in the example and change this composition in one or more intermediate steps until a composition desired by that ordinary person skilled in the art is reached.
  • lipids composition which resem- bles to a larger extent that which is known of the skin, will also display a behaviour more similar to the barrier properties of the skin to be simulated.
  • the chains of the acyl ceramide must have chain lengths differing such that 1 chain thereof must be so much longer than the chain length of the majority of other lipids, that this long chain can be part of two adjacent lipid layers.
  • the inven ⁇ tion is not limited to specific acyl ceramides, at least those acyl ceramides are included of which the first acyl chain has a backbone length of for example 20-42, such as advantageously 28 to 40 carbon atoms, preferably 30 to 32 carbon atoms.
  • the second acyl chain linked to the first acyl chain has a backbone length of 12 to 25 car ⁇ bon atoms, preferably 16-22 carbon atoms.
  • the second chain of the acyl ceramide has a backbone length of 16 to 20 carbon atoms.
  • the ba ⁇ sic structure of the acyl ceramide may be sphingosine, phytosphingos- ine or 6-hydroxysphingosine .
  • a spraying method is understood to be any method of applying droplets to a sup ⁇ port, such that the droplets are smaller than the distance between a nozzle from which a solution is sprayed and the support on which the droplets are sprayed from the nozzle. The droplets are, after coming into contact with the surface of the support, smaller than the sur ⁇ face of the support being covered with lipids.
  • the spraying method may be any known spraying method that does not cause the lipid components of the solution containing lipid mixture to be applied to the support in an unacceptable way, such as a piezo-electric spraying method.
  • a piezo-electric spraying method it is believed that, based on the insight that some lipid components of the solution are better soluble than others, transport of lipids over the surface of the support on which lipids are applied can be limited by means of a spray. It is believed that in this way a more homogeneous lipid membrane may be formed (in particular in the plane of the sup- port) .
  • heat treatment when in the context of the present invention heat treatment is mentioned, this includes the possibility of keeping the support at an elevated temperature during application of the solution, that is, at a temperature above room temperature (25°C) . This enhances the elimi ⁇ nation of the solvent through evaporation.
  • the heat treatment can al- ready be performed by heating during the application (that is, during step c) ) .
  • the heat treatment depends on the lipid composition chosen, and comprises heating to at least 40°C, preferably to at least 5O 0 C.
  • the temperature is advantageously increased to less than 20° below the lowest point of the melting range of that particular lipid mix- ture, preferably to less than 15°, and more preferably to less than 10 °C.
  • the solution containing the lipid mixture contains an unsaturated lipid, and evaporation of the solvent is performed under an inert atmosphere.
  • the unsaturated lipid can be protected against oxidation by oxygen from the atmosphere.
  • the solution containing lipids is applied using an airbrush spraying method.
  • Such a spraying method makes use of a carrier gas, the carrier gas contributing to the evaporation of the solvent from the surface.
  • a carrier gas the carrier gas contributing to the evaporation of the solvent from the surface.
  • the present invention may provide for continuous application of lipid mixture on the support.
  • the airbrush method is particularly suitable when a lipid has to be protected against oxidation by oxygen from its surroundings.
  • the airbrush spraying method is performed using nitrogen or a noble gas as an inert carrier gas .
  • the lipid mixture heated in step d) is cooled without contact with an aqueous solution by at least 15°C, and preferably by at least 20 0 C.
  • the lipid mixture ap- plied to the substrate, apart from acyl ceramides comprises non-acyl ceramides, such that the lipid mixture used contains 5 to 40 mol% acyl ceramide relative to the total of ceramides in the lipid mix ⁇ ture, and preferably 10 to 15 mol% .
  • the lipid mix- ture applied to the substrate comprises cholesterol and a total of the ceramides in a molar ratio of 0,4 to 2.
  • the lipid mixture is present in the solution in such a concentration, that the solution is saturated for at least 50%, preferably at least 65% and more prefera- bly at least 75%.
  • a suitable upper limit is, for example, 95%.
  • to deposit the lipid membrane in thinner layers For example, 25 to 500 thin layers for forming a lipid mem- brane having a total thickness of 15 ⁇ m.
  • a preferred embodi ⁇ ment is characterized in that the lipid mixture is applied in such a quantity that the lipid mixture is applied repeatedly with a layer thickness each time, after drying, of 500 nm or less, preferably 250 nm or less, and more preferably less than 200 nm, such as less than 100 nm, where after each application the solvent is evaporated before the next layer of the lipid mixture is applied.
  • a lipid membrane can be applied on substantially any support by means of the method according to the invention, including for example a medical instrument, such as a tool as well as a utensil such as a catheter, that may come into in contact with a patient, it is preferred for an important application mentioned above - that is, a model system for the skin - that a macro porous support (membrane) is used as the support.
  • a macro porous support membrane
  • the pore size of the support is in the range of 10 to 1000 run, more preferably 25 to 200 ran.
  • Such a membrane (macro porous support) provided with a lipid membrane using the method according to the invention is suitable for model experi ⁇ ments where such membranes provided with a lipid membrane are used instead of stratum corneum obtained from laboratory animals or a hu ⁇ man being.
  • the present invention also relates to a support provided with a lipid membrane applied by means of the method according to the invention.
  • the lipid membrane on the support preferably has a size of at least 0.1 mm 2 , a size for lipid membranes with few defects not achievable without the method according to the invention. In this context, with few defects means that any holes present increase the flux of diffusion through the membrane by at most 50%.
  • the support is a membrane (in the sense of a macro porous support) .
  • Such a membrane as a support has advantageously a pore size of 0.5 ⁇ m or less .
  • the invention relates to the use of a support accord- ing to the invention. More specifically it concerns a method of meas ⁇ uring the permeability of a lipid membrane, wherein a member chosen from a vaccine, a parasite, a drug, a bacterium, a fungus, a peptide, a protein, DNA, RNA, an allergen, a lipid, a solvent and a moistur- iser is applied at one side of a support according to the invention, and the penetration through the support is measured.
  • fig. 1 diagrammatically represents an apparatus suitable for applying lipid layers on a support 1 using the method according to the invention
  • fig. 2 shows a detail of the apparatus of fig. 1 to clarify the operation of the apparatus
  • fig. 3a and b are scanning electron microscopy pictures of supports provided with a lipid membrane, wherein the supports have been subjected to a heat treatment in the presence and absence of an aqueous solution respectively
  • fig. 1 diagrammatically represents an apparatus suitable for applying lipid layers on a support 1 using the method according to the invention
  • fig. 2 shows a detail of the apparatus of fig. 1 to clarify the operation of the apparatus
  • fig. 3a and b are scanning electron microscopy pictures of supports provided with a lipid membrane, wherein the supports have been subjected to a heat treatment in the presence and absence of an aqueous solution respectively
  • fig. 4 is a picture of plates obtained using thin layer chro ⁇ matography, the plates showing the distribution of lipids in the cen- tre of the support (left) and at the periphery thereof (right) re ⁇ spectively, for a support prepared using the method according to the invention
  • fig. 5 corresponds to fig. 4, except that it is for a support not prepared using the method according to the invention (control)
  • fig. 6a and 6b show an X-ray diffraction pattern of a lipid membrane prepared using the method according to the invention, and a graphical representation of the intensity (from left to right, through the centre of fig. 6a) respectively
  • fig. 7 shows the results of diffusion experiments, using iso ⁇ lated humane stratum corneum as a control
  • fig. 8 depicts a graph of a diffusion experiment in the pres ⁇ ence and absence of an acyl ceramide.
  • CERl (C30)-linoleate, CER2 (C24) , CER3(C24), CER3(C16), CER4(C24) and CER6(C24) were gifts from Cosmoferm B.V. (Delft, The Netherlands) . Palmitinic acid, stearic acid, arachidinic acid, beheninic acid, tri- cosanonic acid, lignocerinic acid, cerotinic acid, and cholesterol were purchased from Sigma-Aldrich Chemie GmbH (Schnelldorf, Germany) . All organic solvents used were of analytical quality and made by Lab- scan Ltd (Dublin, Ireland) .
  • a spraying apparatus 1 For spraying the solution containing lipids onto the porous support, use was made of a spraying apparatus 1 as depicted in figure 1. Visi ⁇ ble are a support frame 2 in which an Evolution solo airbrush 3 (Air- brush Service, Almere, The Netherlands) with a nozzle 4 (opening 0.6 mm) is mounted vertically, the nozzle 4 pointing downwardly.
  • an Evolution solo airbrush 3 Air- brush Service, Almere, The Netherlands
  • a nozzle 4 opening 0.6 mm
  • the support frame 2 the frame of a microscope with a substrate table 5 is used, onto which a support A is clamped for the method according to the invention.
  • the focussing means 6 of the microscope the distance between the nozzle 4 and the support A on the substrate table 5 can be set. In the present case, the distance was variable between 2.5 and 8.0 cm.
  • the airbrush 3 is connected to a nitrogen bottle (not shown) via a rapid action coupling of type NW 2.7 mm.
  • a rapid action coupling of type NW 2.7 mm As will be explained hereinafter, in the embodiment discussed below, use is made of two streams of nitrogen having a first high pressure and a second low pressure respectively.
  • the apparatus has a first pressure reducing valve 7 to reduce the nitrogen pressure as present in the nitrogen bottle, to the first high pressure. Nitrogen at his first high pressure passes via conduit 8 to a three-way valve 9 (24 V DC 1.8 W, Kuhnke GmbH, Malente, Germany) .
  • a second pressure reducing valve 10 is provided in a conduit 11 branched off from conduit 8 which is also connected to three-way valve 9.
  • nitrogen is passed under a first high or second low pressure to the airbrush 3 to atomize the solution B respectively to dry the so ⁇ lution B sprayed on the support A.
  • the pressure reducing valves 7 and 10 allow the desired pressure to be set between 0 to 1.6 bar and 0 to 400 mbar, respectively.
  • the pressures used for spraying and drying can be read from the manome ⁇ ters 12 and 13 (tube spring manometer 1401A R40, Eriks BV, Alkmaar, The Netherlands) .
  • the apparatus 1 used for applying a lipid membrane, using the method according to the invention makes it possible to control the duration and the flow rate at which solution B is sprayed.
  • a conduit 15 is connected to a source of compressed air (not shown) to supply compressed air G.
  • the pressure of the compressed air G is reduced to 3 bar using a pressure reducing valve 16, whose pressure can be read from manometer 17.
  • the trigger 14 of the airbrush is opened pneumatically by means of a standard pneumatic actuator unit 20.
  • This unit comprises a rodlet 21 that is kept in the actuator unit 20 in a pushed-in position in the actuator unit 20 by a spring (not shown) , and is brought to a pushed-out posi ⁇ tion by compressed air G.
  • the supply of compressed air G is con ⁇ trolled by valve 23.
  • the rodlet 21 is in a pushed-in po- sition, in figure 2 it is in the pushed-out position.
  • the distance over which the trigger 14 can be moved, and consequently the rate at which solution B can be atomized by the airbrush 3 can be varied with an adjusting screw 19. in the present case, the distance could be set between 0 and 8 mm, whereby 0 mm was the distance at which the trigger 14 is just sufficient to prevent passage of solution B. '
  • the solution containing lipids B is pipetted into the liquid tank 22 of the airbrush from where it is passed via a conduit (not shown) in the airbrush 3 to the nozzle 4, where the solution B is at ⁇ omized.
  • Control of the three-way valve 9 and valve 23 is achieved via an electronic control panel (not shown) .
  • the apparatus 1 described above allows the follow ⁇ ing parameters to be varied: the nitrogen pressure during atomiza- tion, the nitrogen pressure during drying, the distance between the nozzle and the support, the time during which the trigger is opened, the distance over which the trigger is opened, the time period be ⁇ tween 2 consecutive sprays and the total number of sprays after one another and the temperature of the support.
  • the nitrogen pressure during atomiza- tion the nitrogen pressure during drying
  • the distance between the nozzle and the support the time during which the trigger is opened
  • the distance over which the trigger is opened the time period be ⁇ tween 2 consecutive sprays and the total number of sprays after one another and the temperature of the support.
  • the nitrogen pressure maintained high just previous to and during a spray.
  • the nitrogen pressure is reduced immediately after the spraying period until the solvent is evaporated completely. This is checked visually (disap ⁇ pearance of the glossy appearance of the material deposited) .
  • the procedure is repeated until a desired layer thickness of the lipid membrane is achieved.
  • the support A is clamped to the sub- strate table 5. This is necessary to ensure an even surface during spraying and in addition this prevents the support A from being blown away by the nitrogen pressure.
  • the support is placed directly under the nozzle 4 of airbrush 3.
  • a Nuclepore polycarbonate filter is mounted with its glossy side up in a filter holder and is placed on the substrate ta ⁇ ble 5 of the apparatus 1.
  • the distance between the nozzle 4 and the filter, which has a pore size of 50 nm, is about 4.5 cm. Subse ⁇ quently, the following parameters are set: Nitrogen pressure high immediately before and during atomization: 1.16 bar (absolute) .
  • Spraying duration about 1 second.
  • Nitrogen pressure before drying (thus after atomization of solution B on the support) : 160 mbar.
  • Drying duration after each time of spraying about 15 seconds.
  • Distance over which the trigger is opened 5.5 mm
  • volume of the solution applied by spraying 330 ⁇ l.
  • the filters provided with a lipid membrane are subsequently sub ⁇ jected to a heat treatment by heating them for 10 minutes at 7O 0 C on an electrical hot plate.
  • the filters are shielded from the ambient air by means of a glass plate placed above the filters.
  • the filters are re ⁇ moved from the heated plate and are cooled at ambient temperature, the glass plate remaining over the filters.
  • 10 ml 50 mM sodium acetate buffer (pH 5.0) was instead pipetted onto the filter after 10 minutes of heating at 70 0 C. Subsequently, every ⁇ thing as described above, covered with a glass plate, was brought to room temperature .
  • the filters with a lipid membrane were stored under argon in a re ⁇ frigerator until further use .
  • the filters obtained from 3d) are cut to small pieces of about 1.5 x 2 mm 2 , folded and mounted in Tissue-Tek O.C.T. Compound (Miles Inc. Blkhart, IN, US) .
  • the samples are subsequently frozen quickly by plunge-freezing (Reichert Jung-KF80, Vienna, Austria) in liquid propane at -180 0 C.
  • plunge-freezing Reichert Jung-KF80, Vienna, Austria
  • transsec- tional coupes were made using a cryo ultramicrotome (Leica Ul- tracut UCT/Leica EM FCS, Wetzlar, Germany), during which the tem ⁇ perature of the sample was -9O 0 C and the temperature of the knife was -100 0 C.
  • the filter pieces are dried for 3 min at -90 0 C and 0.1 Pa. Subsequently, a layer of platinum was applied by means of sput ⁇ tering (CT 1500 HF, Oxford Instruments, UK) . At least 5 pictures of each filter were taken at -19O 0 C with a field emission scanning elec ⁇ tron microscope (Jeol 6400F, Tokyo, Japan) . Result
  • FIG. 3a and 3b show electron microscopic pictures of a lipid mem ⁇ brane which has been subjected to a heat treatment in the presence of sodium acetate buffer, and a lipid membrane obtained using the method according to the invention, respectively.
  • the layer containing pores, on top in the lower half of each picture, is the support (filter) , whereas the layer on top of that is the lipid membrane.
  • the lipid membrane of the control (fig.
  • the picture of the lipid membrane according to the invention (fig. 3b) reveals a small crack. It can also be seen that the lipid mem- brane has separated from the support. It is believed that these phe ⁇ nomena are artefacts caused during preparation of the lipid membrane concerned for electron microscopic investigation. The phenomena were not observed in other experiments.
  • TLC thin layer chro ⁇ matography
  • Figures 4 and 5 show silica plates developed with copper sulphate, obtained using thin layer chromatography.
  • the left lane of each of 4 and 5 contains the lipids from the centre part, whereas the lane to the right (fig. 4 and 5) contains lipids from the periphery.
  • the lipophilic nature of the lipids decreases from top to bottom: choles ⁇ terol, free fatty acids, ceramides 1 to 6. It can be seen that the distribution of the various lipids in the central part and peripheral part thereof is even for the lipid membrane obtained using the method according to the invention (fig. 4), as the intensities of the lipid bands between the left and right lane are comparable. In contrast, for the control experiment this distribution of lipids (fig. 5) is not homogeneous, the concentration of lipids being 2 mg. In general, if the chromatogram of the outermost ring of the filter and that of the centre differ visually, it is recommended to take one or more of the following measures:
  • X-ray diffraction investigations were performed at the European Syn ⁇ chrotron Radiation Facility (ESRF, Grenoble) using synchrotron radia ⁇ tion at station BM26B.
  • the wavelength of the X-rays was 1.24 A and the distance between the sample and the detector was 1.7 meter.
  • the diffraction data were collected at a 2-dimensional detector.
  • the de ⁇ tector was calibrated with a sample of silver behenate having a thickness of about 1 mm. Tiny pieces of filter (dimensions about 2 by 10 mm) were mounted in a sample holder with mica windows. Measuring time per sample: 5 min.
  • Small angle X-ray scattering was used to obtain information on the orientation and lamellar organisation (the repeat distances of the lamellae) .
  • the scattering intensity I (in arbitrary units) was meas- ured as a function of the scattering vector q (in ran "1 ) .
  • the two reflec ⁇ tions at 1,87 and 3,74 nm "1 marked with an asterisk in fig. 6b) in- dicate that a small portion of the cholesterol crystallizes as sepa ⁇ rate domains.
  • the diffraction pattern largely resembles that of the stratum corneum (not shown) .
  • the donor compartment was filled with 1280 ⁇ l sodium acetate buffer of pH 5.0 in which a model compound was dis ⁇ solved.
  • the experiments were performed using three different model compounds: p-amino benzoic acid (PABA), ethyl-PABA and butyl-PABA.
  • PABA p-amino benzoic acid
  • the acetate buffer was saturated with the model compound in order to obtain equal and maximum thermodynamic activities.
  • the acceptor com ⁇ partment contained phosphate-buffered saline of pH 7.4, and this com ⁇ partment was perfused at a flow rate of about 2 ml/u.
  • the experiments were performed under occlusive conditions (that is: sealed off from the surroundings), wherein the opening of the donor compartment was sealed off with a piece of adhesive tape.
  • the temperature of the stratum corneum or that of the filter with the lipid membrane was kept at 32 0 C, using a thermostat controlled water bath. For a period of 20 hours, with 1 hour intervals, samples (2 ml) from the acceptor compartment were collected in glass tubes. At the end of each experiment the steady state flux and the lag time were determined. This was done by plotting the cumulative amount of each of the model compounds that passed the stratum corneum and the lipid membranes respectively against time. The steady state flux was calcu- lated using linear regression and is equal to the slope of the straight part of the curve. The lag time equals the cut-off of the straight line at the X-axis (that is, the time) .
  • the lipid membranes properly mimic the barrier properties of stratum corneum and that for this reason they are use- ful for permeability measurements.
  • the steady state flux of the most lipophilic compound butyl-PABA is some ⁇ what elevated, whereas a shorter lag time is observed.
  • the lag time is somewhat longer than for stratum corneum. This indicates that the lipid layers are slightly more permeable for lipophilic compounds and slightly less permeable for hydrophilic compounds. This is explained by the fact that the membranes merely consist of lipids on a porous support, whereas the stratum corneum contains hydrophilic components as well.
  • the lipid membranes prepared using the lipid mixture without ceramide 1 did not result in a structure having a long periodicity; the lipid membranes with ceramide 1 did (periodicity 13 nm) .
  • the membranes without a lamellar structure (-A-) are twice as permeable as those (-D-) that do have the structure with long pe ⁇ riodicity.
  • the time t is shown in hours on the X-axis and the permeability F ( ⁇ g/cm 2 /hour) on the Y-axis.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Medicinal Preparation (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)

Abstract

L'invention concerne un procédé pour former une membrane comprenant des couches lipidiques empilées sur un support. Conformément à l'invention, les couches lipidiques sont appliquées sur le support par pulvérisation, après quoi un traitement thermique sans contact avec une solution aqueuse est mis en oeuvre. L'invention permet de former une membrane lipidique homogène (formée par empilement de couches lipidiques de lamelles) sur le support. L'invention se réfère aussi à un support pourvu d'une membrane lipidique essentiellement exempte de trous, et à des applications d'une telle membrane.
PCT/NL2005/000716 2004-10-05 2005-10-05 Procede pour former une membrane lipidique comprenant des couches lipidiques empilees, support pourvu d'une telle membrane et utilisation de celle-ci Ceased WO2006038798A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL1027178A NL1027178C2 (nl) 2004-10-05 2004-10-05 Werkwijze voor het vormen van een lipidenmembraan dat gestapelde lipidenlagen omvat, alsmede een drager voorzien van een lipidenmembraan dat dergelijke gestapelde lipidenlagen omvat.
NL1027178 2004-10-05

Publications (2)

Publication Number Publication Date
WO2006038798A1 true WO2006038798A1 (fr) 2006-04-13
WO2006038798A8 WO2006038798A8 (fr) 2006-10-19

Family

ID=35614193

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/NL2005/000716 Ceased WO2006038798A1 (fr) 2004-10-05 2005-10-05 Procede pour former une membrane lipidique comprenant des couches lipidiques empilees, support pourvu d'une telle membrane et utilisation de celle-ci

Country Status (2)

Country Link
NL (1) NL1027178C2 (fr)
WO (1) WO2006038798A1 (fr)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003011553A1 (fr) * 2001-07-31 2003-02-13 Massachusetts Institute Of Technology Dispositif de production de membrane sur puce

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003011553A1 (fr) * 2001-07-31 2003-02-13 Massachusetts Institute Of Technology Dispositif de production de membrane sur puce

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DE JAGER M W ET AL: "Modelling the stratum corneum lipid organisation with synthetic lipid mixtures: The importance of synthetic ceramide composition", BIOCHIMICA ET BIOPHYSICA ACTA - BIOMEMBRANES 30 AUG 2004 NETHERLANDS, vol. 1664, no. 2, 30 August 2004 (2004-08-30), pages 132 - 140, XP002364634, ISSN: 0005-2736 *
HAUSS T ET AL: "Squalane is in the midplane of the lipid bilayer: Implications for its function as a proton permeability barrier", BIOCHIMICA ET BIOPHYSICA ACTA - BIOENERGETICS 02 DEC 2002 NETHERLANDS, vol. 1556, no. 2-3, 2 December 2002 (2002-12-02), pages 149 - 154, XP002364636, ISSN: 0005-2728 *
JAECKLE E ET AL: "Comparison of effects of different ointment bases on the penetration of ketoprofen through heat-separated human epidermis and artificial lipid barriers", JOURNAL OF PHARMACEUTICAL SCIENCES 01 JUL 2003 UNITED STATES, vol. 92, no. 7, 1 July 2003 (2003-07-01), pages 1396 - 1406, XP002364633, ISSN: 0022-3549 *
KUEMPEL D ET AL: "In vitro reconstitution of stratum corneum lipid lamellae", BIOCHIMICA ET BIOPHYSICA ACTA - BIOMEMBRANES 1998 NETHERLANDS, vol. 1372, no. 1, 1998, pages 135 - 140, XP002364635, ISSN: 0005-2736 *

Also Published As

Publication number Publication date
WO2006038798A8 (fr) 2006-10-19
NL1027178C2 (nl) 2006-04-06

Similar Documents

Publication Publication Date Title
Brown et al. Using monomolecular films to characterize lipid lateral interactions
de Jager et al. A novel in vitro percutaneous penetration model: evaluation of barrier properties with p-aminobenzoic acid and two of its derivatives
Blank et al. An optimized in vitro model of the respiratory tract wall to study particle cell interactions
Lozano et al. Colocalization of the ganglioside GM1 and cholesterol detected by secondary ion mass spectrometry
Ogiso et al. Transfollicular drug delivery: penetration of drugs through human scalp skin and comparison of penetration between scalp and abdominal skins in vitro
US5919576A (en) Immobilized biological membranes
Nygren et al. Localization of cholesterol, phosphocholine and galactosylceramide in rat cerebellar cortex with imaging TOF-SIMS equipped with a bismuth cluster ion source
JP5792074B2 (ja) 経皮薬剤の試験方法と装置
US11892406B2 (en) Method and device for assaying the interaction and dynamics of permeation of a molecule and a lipid bilayer
Mescola et al. Magainin-H2 effects on the permeabilization and mechanical properties of giant unilamellar vesicles
JP5608282B2 (ja) ヒト皮膚様透過性を有するポリマー膜およびこの使用
Aminipour et al. Passive permeability assay of doxorubicin through model cell membranes under cancerous and normal membrane potential conditions
Rondelli et al. Building a biomimetic membrane for neutron reflectivity investigation: Complexity, asymmetry and contrast
Selmin et al. Regenerated keratin membrane to match the in vitro drug diffusion through human epidermis
Hac-Wydro et al. Biomedical applications of the Langmuir monolayer technique
JP2010529478A5 (fr)
WO2006038798A1 (fr) Procede pour former une membrane lipidique comprenant des couches lipidiques empilees, support pourvu d'une telle membrane et utilisation de celle-ci
Wang et al. Layer-by-layer assembly of biologically inert inorganic ions/DNA multilayer films for tunable DNA release by chelation
Ryu et al. Multilayered film for the controlled formation of freestanding lipid bilayers
JP2003533211A (ja) 脂質二重層アレイ方法およびデバイス
Ruben et al. Dimensions of active cytochrome c oxidase in reconstituted liposomes using a gold ball shadow width standard: A freeze‐etch electron microscopy study
Taghizadeh et al. Preparation and in vitro evaluation of a new fentanyl patch based on functional and non-functional pressure sensitive adhesives
TWI531797B (zh) 奈米探針結構及其應用
JP3954847B2 (ja) 脂質膜、膜透過性の測定方法およびスクリーニング方法
CA3137355A1 (fr) Systemes et procedes de depot et de dosages de cibles multiples

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 05791922

Country of ref document: EP

Kind code of ref document: A1